HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Kiyama Selected Research

Hypoglossal Nerve Injuries

4/2001A disintegrin and metalloprotease with thrombospondin type1 motifs (ADAMTS-1) and IL-1 receptor type 1 mRNAs are simultaneously induced in nerve injured motor neurons.
4/2000Akt/protein kinase B prevents injury-induced motoneuron death and accelerates axonal regeneration.
1/2000Morphological changes and expression of protein kinase CK2 beta subunit in the microglia after hypoglossal nerve transection.
1/2000Endothelin-converting enzymes and endothelin receptor B messenger RNAs are expressed in different neural cell species and these messenger RNAs are coordinately induced in neurons and astrocytes respectively following nerve injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Kiyama Research Topics

Disease

4Hypoglossal Nerve Injuries
04/2001 - 01/2000
2Meniere Disease (Menieres Disease)
11/2010 - 12/2008
2Inflammation (Inflammations)
01/2002 - 10/2001
1Muscle Spasticity (Spastic)
01/2014
1Stroke (Strokes)
01/2014
1Traumatic Brain Injuries (Traumatic Brain Injury)
02/2011
1Edema (Dropsy)
11/2010
1Peripheral Nerve Injuries
07/2007
1Wounds and Injuries (Trauma)
08/2006
1Pathologic Dilatation (Ectasia)
12/2004
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2002
1Neoplasms (Cancer)
10/2002
1Uveitis
10/2001
1Sunburn
10/2001
1Hypoxia (Hypoxemia)
02/2001
1Skin Diseases (Skin Disease)
12/2000
1Vohwinkel syndrome
12/2000
1Optic Nerve Injuries
08/2000
1Ganglion Cysts (Ganglion)
08/2000
1Multiple Sclerosis
05/2000
1Demyelinating Diseases (Demyelinating Disease)
05/2000
1Ischemia
04/2000
1Brain Injuries (Brain Injury)
01/2000

Drug/Important Bio-Agent (IBA)

6Messenger RNA (mRNA)IBA
01/2014 - 01/2000
3Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
07/2007 - 10/2001
2Kainic Acid (Kainate)IBA
02/2011 - 04/2000
2Retinaldehyde (Retinal)IBA
10/2001 - 08/2000
1Pharmaceutical PreparationsIBA
01/2014
1salicylhydroxamic acid (SHAM)IBA
01/2014
1BaclofenFDA LinkGeneric
01/2014
1Indicators and Reagents (Reagents)IBA
01/2014
1Aquaporin 2IBA
11/2010
1Aquaporins (Water Channels)IBA
11/2010
1DiureticsIBA
12/2008
1Hormones (Hormone)IBA
12/2008
1Vasopressins (Vasopressin)IBA
12/2008
1damage-induced neuronal endopeptidaseIBA
08/2006
1OxidesIBA
10/2002
1EndotoxinsIBA
10/2001
1Caspase 8 (Caspase-8)IBA
10/2001
1Caspase InhibitorsIBA
10/2001
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
04/2001
1Metalloproteases (Metalloproteinases)IBA
04/2001
1ThrombospondinsIBA
04/2001
1DisintegrinsIBA
04/2001
1Insulin (Novolin)FDA Link
02/2001
1Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2001
1Phosphotransferases (Kinase)IBA
02/2001
1CaspasesIBA
02/2001
1loricrinIBA
12/2000
1Transcription Factors (Transcription Factor)IBA
08/2000
1CytokinesIBA
05/2000
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2000
1MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA
04/2000
1ColchicineFDA LinkGeneric
04/2000
1Endothelin-Converting EnzymesIBA
01/2000
1Casein Kinase II (Casein Kinase 2)IBA
01/2000
1Endothelin Receptors (Endothelin Receptor)IBA
01/2000
1Endothelins (Endothelin)IBA
01/2000

Therapy/Procedure

1Minimally Invasive Surgical Procedures
12/2004
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
12/2004
1Oral Administration
10/2002